SYK - Stryker Corporation

Top Analyst Reports for Apple, Chevron & Accenture

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Chevron Corporation (CVX) and Accenture plc (ACN).

Here's Why You Should Retain Stryker (SYK) Stock for Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

3 Healthcare Trends to Ride for Longevity

Because of their longevity, predictability, and stability, healthcare trends can persist for years. The companies covered today are fundamentally and technically robust stocks currently taking advantage of these trends.

HLN or SYK: Which Is the Better Value Stock Right Now?

HLN vs. SYK: Which Stock Is the Better Value Option?

Which Is the Safer Dividend Stock: Stryker or Medtronic?

Stryker (NYSE: SYK) and Medtronic (NYSE: MDT) are a pair of the biggest and most important medical-device and supply companies out there, but they're a bit different in the stability of the dividend income they offer to investors. Overall, Stryker's business is quite stable: It makes medical equipment, medical instruments, and surgical robotics for healthcare systems worldwide, and there isn't much in the way of rapidly shifting demand for its major segments.​​​​ But it can reliably generate growth by investing in research and development (R&D) to make incremental improvements to its existing products, even if that growth is unlikely to be rapid due to the slow-growing nature of its markets. For example, developing more-advanced hip replacement products for use with its surgical robot system probably won't make investors rich overnight, but it'll keep the top and bottom lines expanding.

Zacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet

Stryker, Boston Scientific, Zimmer Biomet and Insulet are part of the Zacks Industry Outlook article.

4 Medical Products Stocks to Capitalize on the Industry's Recovery

Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, BSX, ZBH and PODD are well-poised to gain from the favorable factors.

Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever

Packing your portfolio with risky hyper-growth stocks might make you feel like a genius during a bull market, but when there's a downturn, your smile just might get turned upside down. As exciting as seeing rapidly rising share prices might be, your portfolio needs to be well-diversified, and that means you need a few companies that are stable in the face of turmoil, not to mention being capable of delivering some growth all the time. Thermo Fisher Scientific (NYSE: TMO) is a sturdy stock that's fit for holding for decades because it's one of the businesses that makes the entire biopharma sector run.

BAX vs. SYK: Which Stock Should Value Investors Buy Now?

BAX vs. SYK: Which Stock Is the Better Value Option?

• 
  Intuitive Surgical, Inc. (ISRG) Gains But Lags Market: What You Should Know

  Zacks
• 
  Union Pacific (UNP) Stock Sinks As Market Gains: What You Should Know

  Zacks

Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves

Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.

Stryker (SYK) Tops Q1 Earnings and Revenue Estimates

Stryker (SYK) delivered earnings and revenue surprises of 7% and 4.91%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

3 Medical Device Stocks Outpacing the Healthcare Industry This Year

Medical device makers are outperforming the general healthcare market so far this year as supply issues ease and the volume of medical procedures is increasing. Three examples are Medtronic (NYSE: MDT), Edwards Lifesciences (NYSE: EW), and Stryker (NYSE: SYK), each of which is up more than 15% this year. The rest of the healthcare industry, on the other hand, has mostly seen its shares decline.

These 3 Stocks Might Be Getting a Little Too Expensive

Its valuation should be very attractive or at least reasonable -- otherwise you may buy at such a steep valuation that the stock will be as likely to retreat as to advance. Here are three promising companies whose stocks seem to have gotten ahead of themselves. Hershey (NYSE: HSY) has been a sweet investment for many people, outpacing the S&P 500 over the past decade with an average annual total return of roughly 14% versus 12% for the benchmark index.

Stryker (SYK) to Report Q1 Earnings: What's in the Cards?

Stryker's (SYK) first-quarter results are expected to reflect strong segmental performances. However, rising costs are likely to have continued hurting margins.

Here's How Much a $1000 Investment in Stryker Made 10 Years Ago Would Be Worth Today

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

HAE vs. SYK: Which Stock Is the Better Value Option?

HAE vs. SYK: Which Stock Is the Better Value Option?

Encompass Health (EHC) Up 32% in 6 Months: More Room to Run?

Encompass Health (EHC) is well-poised for growth on the back of growing facility count within its Inpatient Rehabilitation segment and sound liquidity position.

Stryker (SYK) is a Great Momentum Stock: Should You Buy?

Does Stryker (SYK) have what it takes to be a top stock pick for momentum investors? Let's find out.

2 Top Stocks to Buy in April and Hold Forever

Unfortunately, it's almost certain that there will always be patients with chronic medical conditions requiring treatment from healthcare providers. The good news for these patients is that there are many pharmaceutical and medical device companies working to improve existing treatments. In that light, here are two quality healthcare stocks that could be attractive picks for dividend growth investors to buy this month and hold for decades.

Here's Why You Should Add Stryker (SYK) Stock to Your Portfolio

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the company.

Here's How Much You'd Have If You Invested $1000 in Stryker a Decade Ago

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

Stryker (NYSE:SYK) Could Be A Buy For Its Upcoming Dividend

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Stryker...

MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare

MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.

HAE vs. SYK: Which Stock Should Value Investors Buy Now?

HAE vs. SYK: Which Stock Is the Better Value Option?

ESLOY vs. SYK: Which Stock Is the Better Value Option?

ESLOY vs. SYK: Which Stock Is the Better Value Option?